Dr. Emma Wall
Clinician-researcher in infectious diseases and Long COVID
Long COVID • immune dysregulation • microvascular dysfunction • reverse-translation research • infectious diseases
About the expert
Focus: Patient-led reverse-translation research on Long COVID
Clinician-researcher affiliated with the Francis Crick Institute and University College London (UCL). Runs the UCL Long COVID clinic and serves as Principal Investigator on the Stimulate-ICP trial. Her work characterizes Long COVID as a patient-defined inflammatory illness driven by immune dysregulation and microvascular dysfunction, and pioneers a 'reverse-translation' research model that uses patient experiences to guide laboratory investigation.
Why this matters
Clinician-researcher leading one of Europe's most developed Long COVID research clinics at UCL, working from an inflammatory-disease framework with measurable physical findings. Tends to emphasize patient experience as legitimate research signal and methodological innovation (reverse translation) alongside traditional mechanism-first work. Strongest on European clinical-research methodology; less involved in the autoimmune-mechanism research where Scheibenbogen leads.